Biomarker and diagnostic research for pediatric hepatocellular carcinoma has been reported in the published literature.

Phenotype severity distribution: 4 very common features, 5 common features.

Estimated prevalence: Unknown (Unknown prevalence).

1 clinical trial registered. Interventions under study include drug therapy, other interventions, and procedural interventions. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.

215 publications have been identified in PubMed for pediatric hepatocellular carcinoma. Research spans Basic Science / Preclinical (38%), Review / Meta-Analysis (22%), and Epidemiology / Natural History (12%).

Recent Publications

• Zhang J (2026). [PMID: 41536919](https://pubmed.ncbi.nlm.nih.gov/41536919/). *Bioactive materials*. [Gene Therapy / Novel Therapeutics]

• Yu J (2026). [PMID: 42082186](https://pubmed.ncbi.nlm.nih.gov/42082186/). *Pediatrics*. [Case Report / Case Series]

• Ying S (2026). [PMID: 41883040](https://pubmed.ncbi.nlm.nih.gov/41883040/). *Aliment Pharmacol Ther*. [Other]

• Xing J (2026). [PMID: 41850287](https://pubmed.ncbi.nlm.nih.gov/41850287/). *Cell*. [Gene Therapy / Novel Therapeutics]

• R T (2026). [PMID: 41834287](https://pubmed.ncbi.nlm.nih.gov/41834287/). *Pediatric blood & cancer*. [Case Report / Case Series]

• Huang J (2026). [PMID: 40617410](https://pubmed.ncbi.nlm.nih.gov/40617410/). *J Adv Res*. [Basic Science / Preclinical]

• Massoudi D (2026). [PMID: 41678777](https://pubmed.ncbi.nlm.nih.gov/41678777/). *Hepatology*. [Review / Meta-Analysis]

• Valenzuela-Pérez L (2026). [PMID: 42141897](https://pubmed.ncbi.nlm.nih.gov/42141897/). *Hepatology*. [Basic Science / Preclinical]

• Song IH (2026). [PMID: 40369749](https://pubmed.ncbi.nlm.nih.gov/40369749/). *Cancer Res Treat*. [Epidemiology / Natural History]

• El-Kholy O (2026). [PMID: 41759482](https://pubmed.ncbi.nlm.nih.gov/41759482/). *Curr Res Transl Med*. [Review / Meta-Analysis]